BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 27638043)

  • 1. Mice lacking Faim2 show increased cell death in the MPTP mouse model of Parkinson disease.
    Komnig D; Schulz JB; Reich A; Falkenburger BH
    J Neurochem; 2016 Dec; 139(5):848-857. PubMed ID: 27638043
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Regulation of dopaminergic loss by Fas in a 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine model of Parkinson's disease.
    Hayley S; Crocker SJ; Smith PD; Shree T; Jackson-Lewis V; Przedborski S; Mount M; Slack R; Anisman H; Park DS
    J Neurosci; 2004 Feb; 24(8):2045-53. PubMed ID: 14985447
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Loss of collapsin response mediator protein 4 suppresses dopaminergic neuron death in an 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced mouse model of Parkinson's disease.
    Tonouchi A; Nagai J; Togashi K; Goshima Y; Ohshima T
    J Neurochem; 2016 Jun; 137(5):795-805. PubMed ID: 26991935
    [TBL] [Abstract][Full Text] [Related]  

  • 4. CX3CR1 Disruption Differentially Influences Dopaminergic Neuron Degeneration in Parkinsonian Mice Depending on the Neurotoxin and Route of Administration.
    Tristão FS; Lazzarini M; Martin S; Amar M; Stühmer W; Kirchhoff F; Gomes LA; Lanfumey L; Prediger RD; Sepulveda JE; Del-Bel EA; Raisman-Vozari R
    Neurotox Res; 2016 Apr; 29(3):364-80. PubMed ID: 26403659
    [TBL] [Abstract][Full Text] [Related]  

  • 5. RESP18 deficiency has protective effects in dopaminergic neurons in an MPTP mouse model of Parkinson's disease.
    Su J; Wang H; Yang Y; Wang J; Li H; Huang D; Huang L; Bai X; Yu M; Fei J; Huang F
    Neurochem Int; 2018 Sep; 118():195-204. PubMed ID: 29964075
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Estrogen reduces BDNF level, but maintains dopaminergic cell density in the striatum of MPTP mouse model.
    Tripanichkul W; Gerdprasert O; Jaroensuppaperch EO
    Int J Neurosci; 2010 Jul; 120(7):489-95. PubMed ID: 20583901
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Faim2 contributes to neuroprotection by erythropoietin in transient brain ischemia.
    Komnig D; Gertz K; Habib P; Nolte KW; Meyer T; Brockmann MA; Endres M; Rathkolb B; Hrabě de Angelis M; ; Schulz JB; Falkenburger BH; Reich A
    J Neurochem; 2018 May; 145(3):258-270. PubMed ID: 29315561
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Temporal mRNA profiles of inflammatory mediators in the murine 1-methyl-4-phenyl-1,2,3,6-tetrahydropyrimidine model of Parkinson's disease.
    Pattarini R; Smeyne RJ; Morgan JI
    Neuroscience; 2007 Mar; 145(2):654-68. PubMed ID: 17258864
    [TBL] [Abstract][Full Text] [Related]  

  • 9. ASIC1a Deficient Mice Show Unaltered Neurodegeneration in the Subacute MPTP Model of Parkinson Disease.
    Komnig D; Imgrund S; Reich A; Gründer S; Falkenburger BH
    PLoS One; 2016; 11(11):e0165235. PubMed ID: 27820820
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Age-related severity of dopaminergic neurodegeneration to MPTP neurotoxicity causes motor dysfunction in C57BL/6 mice.
    Ohashi S; Mori A; Kurihara N; Mitsumoto Y; Nakai M
    Neurosci Lett; 2006 Jun; 401(1-2):183-7. PubMed ID: 16581184
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Absence of glia maturation factor protects dopaminergic neurons and improves motor behavior in mouse model of parkinsonism.
    Khan MM; Zaheer S; Thangavel R; Patel M; Kempuraj D; Zaheer A
    Neurochem Res; 2015 May; 40(5):980-90. PubMed ID: 25754447
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Metalloproteinase-9 contributes to inflammatory glia activation and nigro-striatal pathway degeneration in both mouse and monkey models of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)-induced Parkinsonism.
    Annese V; Herrero MT; Di Pentima M; Gomez A; Lombardi L; Ros CM; De Pablos V; Fernandez-Villalba E; De Stefano ME
    Brain Struct Funct; 2015 Mar; 220(2):703-27. PubMed ID: 24558048
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tanshinone I selectively suppresses pro-inflammatory genes expression in activated microglia and prevents nigrostriatal dopaminergic neurodegeneration in a mouse model of Parkinson's disease.
    Wang S; Jing H; Yang H; Liu Z; Guo H; Chai L; Hu L
    J Ethnopharmacol; 2015 Apr; 164():247-55. PubMed ID: 25666429
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Small molecule TrkB agonist deoxygedunin protects nigrostriatal dopaminergic neurons from 6-OHDA and MPTP induced neurotoxicity in rodents.
    Nie S; Xu Y; Chen G; Ma K; Han C; Guo Z; Zhang Z; Ye K; Cao X
    Neuropharmacology; 2015 Dec; 99():448-58. PubMed ID: 26282118
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Participation of perforin in mediating dopaminergic neuron loss in MPTP-induced Parkinson's disease in mice.
    Peng SP; Zhang Y; Copray S; Schachner M; Shen YQ
    Biochem Biophys Res Commun; 2017 Mar; 484(3):618-622. PubMed ID: 28137589
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Neuroprotection in Parkinson models varies with toxin administration protocol.
    Anderson DW; Bradbury KA; Schneider JS
    Eur J Neurosci; 2006 Dec; 24(11):3174-82. PubMed ID: 17156378
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dopamine receptor D3 expressed on CD4+ T cells favors neurodegeneration of dopaminergic neurons during Parkinson's disease.
    González H; Contreras F; Prado C; Elgueta D; Franz D; Bernales S; Pacheco R
    J Immunol; 2013 May; 190(10):5048-56. PubMed ID: 23589621
    [TBL] [Abstract][Full Text] [Related]  

  • 18. DAP12 and CD11b contribute to the microglial-induced death of dopaminergic neurons in vitro but not in vivo in the MPTP mouse model of Parkinson's disease.
    Kinugawa K; Monnet Y; Béchade C; Alvarez-Fischer D; Hirsch EC; Bessis A; Hunot S
    J Neuroinflammation; 2013 Jul; 10():82. PubMed ID: 23844828
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Isotopic reinforcement of essential polyunsaturated fatty acids diminishes nigrostriatal degeneration in a mouse model of Parkinson's disease.
    Shchepinov MS; Chou VP; Pollock E; Langston JW; Cantor CR; Molinari RJ; Manning-Boğ AB
    Toxicol Lett; 2011 Nov; 207(2):97-103. PubMed ID: 21906664
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Low dose pramipexole is neuroprotective in the MPTP mouse model of Parkinson's disease, and downregulates the dopamine transporter via the D3 receptor.
    Joyce JN; Woolsey C; Ryoo H; Borwege S; Hagner D
    BMC Biol; 2004 Oct; 2():22. PubMed ID: 15473914
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.